[Elsevier] Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial

Cebollino Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-04 03:57
Reward10points

Publication History:
Published July 9, 2026

DOI: 10.1016/S0140-6736(26)00760-9

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list